Synthetic therapeutic gene circuits in mammalian cells
- PMID: 24844435
- DOI: 10.1016/j.febslet.2014.05.003
Synthetic therapeutic gene circuits in mammalian cells
Abstract
In the emerging field of synthetic biology, scientists are focusing on designing and creating functional devices, systems, and organisms with novel functions by engineering and assembling standardised biological building blocks. The progress of synthetic biology has significantly advanced the design of functional gene networks that can reprogram metabolic activities in mammalian cells and provide new therapeutic opportunities for future gene- and cell-based therapies. In this review, we describe the most recent advances in synthetic mammalian gene networks designed for biomedical applications, including how these synthetic therapeutic gene circuits can be assembled to control signalling networks and applied to treat metabolic disorders, cancer, and immune diseases. We conclude by discussing the various challenges and future prospects of using synthetic mammalian gene networks for disease therapy.
Keywords: Cell therapy; Gene circuits; Gene regulation; Gene therapy; Synthetic biology.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Synthetic mammalian gene circuits for biomedical applications.Curr Opin Chem Biol. 2013 Dec;17(6):910-7. doi: 10.1016/j.cbpa.2013.10.006. Curr Opin Chem Biol. 2013. PMID: 24466575 Review.
-
Therapeutic synthetic gene networks.Curr Opin Biotechnol. 2012 Oct;23(5):703-11. doi: 10.1016/j.copbio.2012.01.003. Epub 2012 Feb 1. Curr Opin Biotechnol. 2012. PMID: 22305476 Review.
-
Engineering Mammalian Designer Cells for the Treatment of Metabolic Diseases.Biotechnol J. 2018 May;13(5):e1700160. doi: 10.1002/biot.201700160. Epub 2017 Nov 29. Biotechnol J. 2018. PMID: 29144600 Review.
-
From gene switches to mammalian designer cells: present and future prospects.Trends Biotechnol. 2013 Mar;31(3):155-68. doi: 10.1016/j.tibtech.2012.11.006. Epub 2012 Dec 13. Trends Biotechnol. 2013. PMID: 23245728 Review.
-
Synthetic biology moving into the clinic.Science. 2011 Sep 2;333(6047):1248-52. doi: 10.1126/science.1206843. Science. 2011. PMID: 21885773 Review.
Cited by
-
Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cells.Sci Rep. 2016 Sep 2;6:30798. doi: 10.1038/srep30798. Sci Rep. 2016. PMID: 27586866 Free PMC article.
-
Recent Progress on Systems and Synthetic Biology Approaches to Engineer Fungi As Microbial Cell Factories.Curr Genomics. 2016 Apr;17(2):85-98. doi: 10.2174/1389202917666151116212255. Curr Genomics. 2016. PMID: 27226765 Free PMC article.
-
AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation.Nat Commun. 2024 Feb 6;15(1):1122. doi: 10.1038/s41467-024-45383-z. Nat Commun. 2024. PMID: 38321056 Free PMC article.
-
Histidine switch controlling pH-dependent protein folding and DNA binding in a transcription factor at the core of synthetic network devices.Mol Biosyst. 2016 Jul 19;12(8):2417-26. doi: 10.1039/c6mb00304d. Mol Biosyst. 2016. PMID: 27282811 Free PMC article.
-
Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling.J Vis Exp. 2015 Jun 25;(100):e52903. doi: 10.3791/52903. J Vis Exp. 2015. PMID: 26168006 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical